Assessment of in vitro heparin complement regulation capacity during real-time cell analyzer antibody-mediated cytolysis assay: Compatibility studies for pig-to-baboon xenotransplantation

Transplantation Proceedings

Volumn 44, Issue 6, 2012, Pages 1584-1588

  Ramis, G ^a   Martinez Alarcon L ^b   Majado, M J ^b   Quereda, J J ^a   Mendonca L ^a,c   Herrero Medrano, J M ^a   Abellaneda, J M ^a   Rios A ^b   Lopez Navas A ^b   Ramirez P ^b   Munoz A ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ANALYZER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY MEDIATED CYTOLYSIS; BABOON; BIOCOMPATIBILITY; CELL STRUCTURE; COMPUTER PROGRAM; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLYSIS; FIBROBLAST; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REAL TIME CELL ANALYZER SYSTEM; TRANSGENIC PIG; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD46; ANTIGENS, CD59; AREA UNDER CURVE; CELLS, CULTURED; COMPLEMENT ACTIVATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; FEMALE; FIBROBLASTS; HEPARIN; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PAPIO ANUBIS; SERUM; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84864414517     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.05.015     Document Type: Conference Paper

References (18)

1. L. Martínez-Alarcón, A. Ríos, J.A. Pons Attitudinal study of organ xenotransplantation in patients on the kidney and liver transplant waiting list in a country with a high rate of deceased donation Xenotransplantation 18 2011 168
2. M. Loss, B. Vangerow, J. Schmidtko Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model Xenotransplantation 7 2000 186
3. E. Raepple, H.U. Hill, M. Loos Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4 Immunochemistry 13 1976 251
4. M. Loos, J.E. Volanakis, R.M. Stroud Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement HI, Inhibition of C4 and C2 binding site(s) on C1s by polyanions Immunochemistry 13 1976 789
5. M. Loos, J.E. Volanakis, R.M. Stroud Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement II. Effect of polyanions on the binding of C2 to EAC4b Immunochemistry 13 1976 257
6. J.M. Weiler, R.W. Yurt, D.T. Ferain Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin J Exp Med 147 1978 409
7. J.M. Weiler, R.E. Edens, R.J. Linhardt Heparin and modified heparin inhibit complement activation in vivo J Immunol 148 1992 3210
8. P.O. Denk, M. Knorr Effect of heparin on human corneal fibroblast proliferation in vitro with and without growth factor stimulation Graefes Arch Clin Exp Ophthalmol 237 1999 342
9. H.G. Garg, B.T. Thompson, A.C. Hales Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol 279 2000 779
10. B. Yilmaz, C. Birai-Avcic, C. Gündüz Effect of heparin on human skin fibroblast proliferation in vitro Ege Tip Dergisi 45 2006 175
11. G. Ramis, L. Martínez-Alarcón, M.J. Majado Donor-graft compatibility tests in pig-to-primate xenotransplantation model: serum versus plasma in real-time cell analyzer trials Transplant Proc 43 2011 249
12. J.J. Quereda, L. Martínez-Alarcón, L. Mendoça Validation of xCELLigence real-time cell analyzer to assess compatibility in xenotransplantation with pig-to-baboon model Transplant Proc 42 2010 3239
13. Vilasi S, Sarcina R, Maritato R, et al. Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro. PLoS ONE 6(7):e22076
14. J.J. Castellot, D. Cochran, M. Karnovsky Effects of heparin on vascular smooth muscle cells I. Cell metabolisms J Cell Physiol 124 1985 21
15. D. Letourneur, B.L. Caleb, J.J. Castellot Heparin binding, internalization and metabolism in vascular smooth muscle cells: I Upregulation of heparin binding correlaties with antiproliferative activity J Cell Physiol 163 1995 61
16. M. Heroult, I. Bernard-Pierrot, J. Delbe Heparin affine regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis Oncogene 23 2004 1745
17. H.G. Garg, N. Cindhuchao, D.A. Quinn Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation Carbohydr Res 337 2002 2359
18. L. Yua, D.A. Quinna, H.G. Garga Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension Biochem Biophys Res Commun 34 2006 1565